Prescription Medicines Schedule




NEW ZEALAND GAZETTE, No. 77 — 3 AUGUST 2017

Dermatophagoides pteronyssinus

Desogestrel; except when supplied for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

Di-iodohydroxy quinoline; except when specified elsewhere in this notice

Dimiracetam (and its stereoisomers)

Diphtheria, tetanus and pertussis (acellular, component) vaccine; except when administered in a single dose to a person 18 years of age or over or to a pregnant woman aged 13 years and over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

Doliracetam (and its stereoisomers)

Dupracetam

Elbasvir

Elosulfase alfa

Elotuzumab

Eluxadoline

Esomeprazole; except when specified elsewhere in this notice

Ethinyloestradiol; except when supplied at a strength of 35 micrograms or less in combination with either levonorgestrel or norethisterone for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

Etiracetam

Fasoracetam (and its stereoisomers)

Felbamate

Felypressin; except when combined with a local anaesthetic and used in practice by a dental therapist or oral health therapist registered with the Dental Council

Fibroblast growth factors

Flubromazolam

Flunarizine

Follitropin delta

Fomepizole

Fonturacetam (and its stereoisomers)

Glecaprevir

Grazoprevir

Growth Hormone Releasing Hormones

Growth Hormone Releasing Peptide-6

Growth Hormone Releasing Peptides

Hexyl aminolevulinate

Idarucizumab

Idebenone

Idelalisib

Imuracetam

Influenza vaccine; except when administered to a person 13 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

Ixazomib

45



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 77





✨ LLM interpretation of page content

🏥 Schedule 1 - Prescription Medicines (continued from previous page)

🏥 Health & Social Welfare
Prescription Medicines, Schedule, Desogestrel, Di-iodohydroxy quinoline, Dimiracetam, Diphtheria vaccine, Doliracetam, Dupracetam, Elbasvir, Elosulfase alfa, Elotuzumab, Eluxadoline, Esomeprazole, Ethinyloestradiol, Etiracetam, Fasoracetam, Felbamate, Felypressin, Fibroblast growth factors, Flubromazolam, Flunarizine, Follitropin delta, Fomepizole, Fonturacetam, Glecaprevir, Grazoprevir, Growth Hormone Releasing Hormones, Growth Hormone Releasing Peptide-6, Growth Hormone Releasing Peptides, Hexyl aminolevulinate, Idarucizumab, Idebenone, Idelalisib, Imuracetam, Influenza vaccine, Ixazomib